Effect of CYP3A4(∗)1G and CYP3A5(∗)3 Polymorphisms on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects

Ticagrelor is the first reversible, direct-acting, potent P2Y(12) receptor antagonist in management of acute coronary syndromes. It is rapidly absorbed and extensively metabolized. AR-C124910XX, the major active metabolite, antagonizes the P2Y(12) receptor at approximately equal potency. The metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuaibing, Shi, Xiangfen, Tian, Xin, Zhang, Xiaojian, Sun, Zhiyong, Miao, Liyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374142/
https://www.ncbi.nlm.nih.gov/pubmed/28408884
http://dx.doi.org/10.3389/fphar.2017.00176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374142/
https://www.ncbi.nlm.nih.gov/pubmed/28408884
http://dx.doi.org/10.3389/fphar.2017.00176

Ejemplares similares